InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Vickers Philip J., Director. Officer active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 5 disclosures have been recorded. Total volume traded: €68k. The latest transaction was filed on 4 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
06,059 shares0
Common Stock
SEC:0001479290-22-000064:0·
€33,9854,800 shares@ €7.0802100.0% of flow
Common Stock
SEC:0001127602-21-021729·
Ideal exit: 3 Apr 2022 (T+270)
€33,9854,800 shares@ €7.080250.0% of flow
Common Stock
SEC:0001127602-21-021729:0·
Ideal exit: 3 Apr 2022 (T+270)
04,013 shares0
Common Stock
SEC:0001479290-21-000116·
04,013 shares0
Common Stock
SEC:0001479290-21-000116:0·
5 of 5 declarations
About Vickers Philip J.
Philip J. Vickers is a Board Member at Revance Therapeutics, Inc. and AVROBIO, Inc. In this role, he contributes to the governance of these companies, bringing his expertise to the board. Revance Therapeutics is a biopharmaceutical company, while AVROBIO focuses on gene therapy. Mr. Vickers's experience in these sectors is valuable for guiding strategic decisions.
